Siemens Healthcare Diagnostics Inc., a life sciences unit of Siemens AG of Germany, has leased a floor in the Smithsonian Astrophysical Institute Observatory at Cambridge Discovery Park, the park's owner said today.
The park's owner is the Bulfinch Cos. Inc. of Needham, a real estate investment and development firm.
Cambridge Discovery Park is a 27-acre campus in Cambridge masterplanned to accommodate an additional 700,000 square feet of office, laboratory, and research and development buildings when fully completed, said Bulfinch, which added that the park fronts Route 2 and is in close proximity to Route 128, the Alewife MBTA station, and Downtown Boston; the recent completion of the six-story Smithsonian Astrophysical Institute Observatory signaled the first phase of development within the park.
Oncogene Science Biomarker Group, a Siemens Healthcare unit that is looking to develop advances in oncology care, will occupy nearly 23,000 square feet of space at the Smithsonian building, Bulfinch said.
Siemens was represented in the transaction by CB Richard Ellis New England, and Richards Barry Joyce & Partners represented Bulfinch, Bulfinch said.
"Cambridge Discovery Park is an ideal setting for a premiere research company such as Siemens," Michael Wilcox, vice president and director of leasing at Bulfinch, said in a statement. "We are pleased that they selected CDP for their office and laboratory operations, where they will join other leading research firms such as FoldRx, the Harvard-Smithsonian Astrophysical Institute, and TIAX LLC. We look forward to accommodating Siemens’ growing needs as the park evolves into future phases of developmment to its 820,000 square foot build-out.”
Last month, a Globe story noted that Siemens Healthcare was about to celebrate a ribbon-cutting for its expansion in Walpole. The company said then that it had added 115,000 square feet to its manufacturing plant and that it planned to add 70 jobs over the next decade.
(By Chris Reidy, Globe staff)